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Abstract 
A prototype experimental stealth bacterins were developed from human uro-pathogens are going to 
evaluated  both at the in-vitro and in-vivo levels. The immune  features  were explored for the antigenic  
relationships between  a stealth bacterins for the human  uro-pathogen surface agglutino-gens to that of 
intact forms of the same species and how they are different in the different species. For this purpose the 
elected  uro-pathogens were E. coli and S.aureus. Bacterins were prepared both from the stealth and the 
intact forms of the same species. lapin immune system are being elected for the simulation of human 
immune system .Immunization and hyper-immunization protocols were applied. Agglutination, cross-
agglutination and reciprocal cross-agglutinin absorption were performed for the same species .It was 
evident that the share antigenic epitopes of the studied stealth and intact  bacterins were; Surface 
located, in-common, particulate ,agglutino-genic, with an apparent quantitative rather qualitative 
differences. Sunflower oil  combined bacterins augment  stealth pathogen bacterins immune responses 
of up to eight to ten folds than without the oil combinations .The stealth  bacterins were found safe, 
antigenic and immunogenic in a lapin model.  
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1. Introduction  
E.coli and S.aureus are being in rating of principle human uro-pathogens in this and other areas  of the 
world [1.2]. Human persistent pyuria was rather common uro-pathology associated with these 
pathogens in their stealth forms mostly [3,4,5]. The stealth cell wall defective bacterial immunogens in 
suitable mammalian  host can  simulate one or more of  the human immune responses such as 
;Antibody responses, immediate hypersensitivity ,delayed type hypersensitivity ,granuloma formation 
and autoimmune responses [6,7,8,9].The  aim of the  present work was to develop  and evaluate a 
prototype  candidate experimental stealth and intact  bacterins for E.coli and S.aureus  in lapin models. 
2. Materials and Methods   
The bacterin strains were obtained from persistent pyuria  clinical cases. They were identified  by the 
manual biochemical tests, API 20 approach and Viteck devise system and determined as E.coli and S. 
aureus [10,11].The stealth cell wall defective bacterins were prepared as in [12,13].The whole cell 
intact bacterins were done as per methods of [14,15]The density of bacterin units per unit volume was 
made matching 10 IU WHO  standard opacity tube The immunization protocols are of multisite 
injection nature[16 ]Handling and care of rabbits was done  in accordance with the guidelines  for  
research on rabbit implemented by the international council of laboratory animal science. The priming 
doses for rabbits  were  2 ml of bacterin,2ml of bacterin plus oil in three dosage manner  in a week a 
part followed by one week  leave then  test bleed for the test and the control groups ,Table 1. The 
agglutinin, cross-agglutinin and reciprocal cross agglutinin tests were done as in [17,18].   
Table 1: Rabbits Immunization Groups 
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3. Results  
3.1 In-vitro evaluation Parameters 
The stealth and intact bacterin strains and bacterin suspensions were; stable, pure and homogenous. 
3.2 In-vivo  evaluation Parameters 
3.3 Safety 
The four prototype bacterins candidates were found to be nontoxic safe by the fact of absence of comorbidity 
and co mortality on applying the immunization programs to the test rabbits. 
3.4 Identity 
There were reasonable high specific antibody titres for each of the prepared bacterin with their own lapin  
immune sera indicating immune identity. 
3.5 The Immune Features of the Human  uro-pathopgenic   S.aureus  Bacterins 
Group 1 bacterin when reacted with its own specific polyclonal non-absorbed immune serum showed agglutinin  
titre of 4266.But when reacted  with group 2 specific polyclonal non-absorbed immune serum it was  with the 
agglutinin titre of160. 
The first represents the homologus reaction and the second represent the heterologous reaction. While when 
Group 2  bacterin reacted with its own specific polyclonal unabsorbed immune serum has shown agglutinin 
titres of  426 . group  3  have shown mean titers of 47788. Absorption and cross absorption studies nullify the 
titres in either cases Tables 2.  
3.6 The Immune Features of Human Uropathogenic  Uropathogenic  E.coli Bacterins 
Group 5 bacterins on reaction with its own specific non-absorbed immune serum the agglutinin titre means were 
1706. 
Similarly,Group  6  bacterins when reacted with its own specific immune serum gave  a titre of  466. 
While when group V bacterins reacted with group  6  immune serum it has shown a titre of 320 and that of 
group VI with that of V it gave a titre means of immune serum 160 Group  7  bacterin  reacted with its own 
specific   immune serum to agglutinin titre mean of 68106.Absorption ,Reciprocal  absorption studies nullify  
the titres in either cases Tables 2, 
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Table 2: The lapin antibody responses to the four prototype candidate bacterins 
Rabbit Groups Mean of the specific antibody titres 
S. aureus  Bacterins 
Group             1 
Group             2 
Group             3 
Group             4 
E.coli Bacterins 
Group              5 
Group              6 
Group              7 
Group              8 
 
4266* 
426 
47786 
426 
 
1706* 
426 
68106 
2133 
*Mean of three readings for the antibody titres. 
Table 3: Lapin  Humoral Immune responses to S.aureus  bacterins 
Bacterins UNI* serum UNII serum AB I** serum ABII serum 
Stealth S.aureus 4266 160 O O 
Intact S.aureus 160 426 O O 
*Un =Unabsorbed serum Group I,GroupII  ***AB absorbed  group I,II sera 
Table 4: Lapin Humoral Immune responses to E.coli Bacterins 
Bacterins  UN V* serum UN VI serum AB** V serum ABVI serum 
Stealth E.coli 1706 320 O O 
Intact E.coli 160 426 O O 
 
4. Discussion 
The vaccinology of  stealth cell wall defective bacterins  seems to be in  in its    infancy  stages  so far literature 
screen indicated[ 19,20 ] and  the area is still virgin .Hence, the present work appeared  as novel contribution . 
Agglutination ,cross agglutination ,absorption, and  reciprocal cross absorption assays are to date[last five years]  
in-common  use among microbial immunologists  as compared to little or no use among non-microbial 
immunologists[21,22,23,24,25]. Hence, it  was followed in this work. Preparing cell wall defective stealth uro-
pathogens bacterins and evaluating; identity, antigenicity ,immunogenicity and shared antigenicity are 
constituting basic steps in stealth bacterin candidate preparations and evaluations to the level of experimental 
vaccines[ 20 ].The reaction between homologous agglutinogens with their own immune sera have shown high 
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titres which may be due to the presence of high epi-paratope units in the reaction mixture in contraindication 
with the heterologous reactions with possible existence  of low epi-paratope units in the reaction mixtures. This 
besides that on absorption homologous absorption agglutinogens absorb more para -topes than the heterologous 
ones [19]. These stealth bacterins may offer opportunity for being as autogenous  therapeutic  vaccines for both 
of these uropathogens in  cases persistent pyuria [26]. The documented shared antigenic fraction(s) may have 
the potential to be prototype molecular vaccine for bacterial uropathogenesis, that’s why it gots such importance 
and focus  in the present work. The shred antigenic fraction may have several features as; Surface located, 
agglutinogenic, of bilateral nature and quantitative rather than qualitative character, and their immunogenicity 
was augmented by sunflower oil [SFO],which may be due to the formation of depot forming units, antigen 
targeting and activation of the cytokine networks. The action of SFO may simulate the action of Freund In 
complete Adjuvant [16,19]. In addition to species to species difference in bacterin immunogenicity. The 
evaluation parameters are  presented in the Table 5. 
Table 5: The evaluation of the  experimental uropathogenic bacterins 
Features[19,28] St.S.aureus[ 
26, 27] 
St.E.coli 
[26] 
Stealth 
S.aureus 
Stealth 
E.coli 
Intact 
S.aureus 
Intact 
E.coli 
Underestanding disease U U U U U U 
Understanding the causal  
U 
 
U 
 
U 
 
U 
 
U 
 
U 
Preparation of candidate 
bacterin 
 
P 
 
P 
 
P 
 
P 
 
P 
 
P 
Lab.Animal 
Studies:Safety 
 
Safe 
 
Safe 
 
Safe 
 
Safe 
 
Safe 
 
Safe 
Lab.Animal 
Studies:Antigenicity 
 
Antigenic 
 
Antigenic 
 
Antigenic 
 
Antigenic 
 
Antigenic 
 
Antigenic 
Lab.Animal Studies: 
Immunogenicity 
 
Imm. 
 
Imm. 
 
Imm. 
 
Imm. 
 
Imm. 
 
Imm. 
        U=Understanding                           P=Prepared.                               St.=Standard 
5. Conclusion  
Stealth bacterins were prepared from the uro- pathgenic  S. aureus and E.coli. The bacterins were found safe, 
antigenic and immunogenic in a lapin models. These stealth bacterins have high immunogenic potentials than 
that intact  forms of the same species. Stealth forms shared an antigenic fraction with those of intact forms of the 
same  species. They may constitute candidate experimental stealth therapeutic  bacterins for persistent pyuria in 
man under well controlled trails. 
6. Recommendations 
Evaluation of the other human stealth bacterial uro-pathogens for their possible utility as prototype candidate 
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bacterins. As well as a try to use them for the therapy of elected cases of stealth pathogen associated bacterial 
persistent pyuria in man under well controlled trails. 
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